
Nuvista Pharmaceuticals Private Limited
Manufactures and distributes surgical instruments, medical and diagnostic equipment.
Manufactures and distributes surgical instruments, medical and diagnostic equipment.
Nuvista Pharmaceuticals Private Limited (NPPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 March 2017 (Eight years and one month 8 days old ). Its registered office is in Rangareddy, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.90 Cr and a paid-up capital of Rs 1.90 Cr.
The company currently has active open charges totaling ₹5.00 M. The company has closed loans amounting to ₹9.50 M, as per Ministry of Corporate Affairs (MCA) records.
Surya Yechuri, Masaram Goud, Kallam Reddy, and Two other members serve as directors at the Company.
Rangareddy, Telangana, India
+91-XXXXXXXXXX
U24304TG2017PTC115996
115996
Private Limited Indian Non-Government Company
20 Mar 2017
30 Sep 2024
31 Mar 2024
Unlisted
Roc Hyderabad
Name | Designation | Appointment Date | Status |
---|---|---|---|
Surya Yechuri ![]() | Managing Director | 20-Mar-2017 | Current |
Name | Designation | Appointment Date | Status |
---|---|---|---|
Masaram Goud ![]() | Director | 20-Mar-2017 | Current |
Kallam Reddy ![]() | Director | 20-Mar-2017 | Current |
Jakkajangreddy ![]() | Director | 18-May-2017 | Current |
Sudhakara Kalakota ![]() | Director | 17-Sep-2021 | Current |
Nuvista Pharmaceuticals Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 4.49% increase. The company also saw a substantial fall in profitability, with a 62.16% decrease in profit. The company's net worth dipped by a decrease of 1.55%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2023, Nuvista Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Sudhakara Kalakota is a mutual person
Sudhakara Kalakota is a mutual person
₹0.50 Cr
₹0.95 Cr
Date | Lender | Amount | Status |
---|---|---|---|
15 Mar 2024 | Others | ₹5.00 M | Open |
21 Aug 2018 | Others | ₹9.50 M | Satisfied |
Nuvista Pharmaceuticals has a workforce of 28 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Nuvista Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nuvista Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Nuvista Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Nuvista Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
A charge registered on 21 Aug 2018 via Charge ID 100202194 with Others was fully satisfied on 26 Mar 2024.
A charge with Others amounted to Rs. 0.50 Cr with Charge ID 100889675 was registered on 15 Mar 2024.
Sudhakara Reddy Kalakota was appointed as a Director was appointed as a Director on 17 Sep 2021 & has been associated with this company since 3 years 7 months .
A charge with Others amounted to Rs. 0.95 Cr with Charge ID 100202194 was registered on 21 Aug 2018.
Nuvista Pharmaceuticals Private Limited was incorporated on 20 Mar 2017.
The authorized share capital of Nuvista Pharmaceuticals Private Limited is ₹ 1.90 Cr and paid-up capital is ₹ 1.90 Cr.
Currently 5 directors are associated with Nuvista Pharmaceuticals Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Nuvista Pharmaceuticals Private Limited is Shed No 48 Phase Ii, Ida Mallapur India, Hyderabad, Telangana, 500076.
The corporate identification number (CIN) of Nuvista Pharmaceuticals Private Limited is U24304TG2017PTC115996 and the company number is 115996 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2023, the revenue trend for Nuvista Pharmaceuticals Private Limited has risen by 4.49%.
As Per 2023 financial reports, 28 employees are currently employed by Nuvista Pharmaceuticals Private Limited.
The financial reports for the fiscal year 2023 indicates that The net worth of Nuvista Pharmaceuticals Private Limited has experienced an downturn of -1.55%.
As per the financial statements for fiscal Year 2023, The total open charges for Nuvista Pharmaceuticals Private Limited amount to ₹ 5.00 M.
The most recent Balance Sheet for Nuvista Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2024.
Search company & director profiles for free and gain access to critical business data.
SS
MK